The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects in some cases. Antibody-drug conjugates ...

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

Anktiva is combined with BCG, or Bacillus Calmette-Guérin, an immunotherapy drug delivered to the bladder through a catheter. It’s intended for people who have non-muscle invasive bladder cancer, or ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Los Angeles News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...